A comparative study of alevaire and a new mucolytic agent, acumist in postoperative patients.
D000328:Adult; D000368:Aged; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002254:Carbonates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003300:Copper / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009093:Mucus / Q000187:drug effects*; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control; D012138:Respiratory Therapy; D013183:Sputum / Q000378:metabolism*; D013431:Sulfates / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*; D013903:Thoracic Surgery; D013909:Thorax / Q000601:surgery*; D014783:Viscosity
D002254:Carbonates; D013431:Sulfates; D013501:Surface-Active Agents; D003300:Copper; D001205:Ascorbic Acid